IPTC NewsCodes: 20000189

Layoffs, Downsizing

Kexing, Chengye Inactivation-Titanium Media Official Website

Post date May 17, 2022 — 17:15 Post Lock

Green Valley Pharma's Phase 9-1 overseas clinical trial terminated, how difficult is it to develop Alzheimer's disease drugs

Post date May 16, 2022 — 21:32 Post Lock

[CV Morning Reading] Shanghai will promote the resumption of business and the market in stages from today, and it is rumored that Gome will lay off 40% of its employees – yqqlm

Post date May 16, 2022 — 11:25 Post Lock

The dawn of the film industry is quiet

Post date May 15, 2022 — 08:35 Post Lock

What is the salary level of A-share listed companies in 2021? Some companies cut wages by more than 60%, and some reduced their employees by more than 10,000 people

Post date May 13, 2022 — 21:15 Post Lock

In 2021, China Mobile, New Hope and other 14 A-share companies will reduce staff by more than 10,000

Post date May 13, 2022 — 15:31 Post Lock

In 2021, 14 A-share companies such as China Mobile and New Hope will reduce their staff by more than 10,000, and companies will cut their wages by more than 60%.

Post date May 13, 2022 — 15:29 Post Lock

Focus on the "new geography" of the capital market丨In the 2.0 era, can Shenzhen's cross-border e-commerce continue to lead?

Post date May 13, 2022 — 10:23 Post Lock

In the 2.0 era, can Shenzhen's cross-border e-commerce continue to lead? -Technology Channel-Hexun.com

Post date May 13, 2022 — 06:44 Post Lock

Saudi Aramco replaced Apple as the world's largest market capitalization; SEC added 11 more Chinese concept stocks to pre-delisting Teller Report

Post date May 12, 2022 — 13:25 Post Lock

The last glory of Web2.0, is Douyin really going to be listed this time? _Shenzhen Hotline

Post date May 11, 2022 — 11:12 Post Lock

Weixing has been surveyed by 10 institutions: the company's 2021 annual report has planned the 2022 performance target, and the 2022 performance target is expected to increase by about 15% year-on-year (with survey questions and answers)

Post date May 11, 2022 — 11:09 Post Lock

Nuggets for innovative drugs Junshi Bio’s new crown drug is in Phase III clinical trial and Pfizer’s Paxlovid conducts head-to-head clinical research

Post date May 9, 2022 — 02:16 Post Lock

Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research

Post date May 8, 2022 — 17:33 Post Lock

Accused of layoffs before the year-end bonus, Beijing Kexing Zhongwei's net profit in 2021 will exceed 80 billion – yqqlm

Post date May 8, 2022 — 16:05 Post Lock

Nuggets Innovative Drugs｜Junshi Bio’s new crown drug is in Phase III clinical trial and Pfizer’s Paxlovid conducts head-to-head clinical research

Post date May 8, 2022 — 15:50 Post Lock

Nuggets Innovative Drugs Junshi Bio’s new crown drug is in Phase III clinical trials with Pfizer’s Paxlovid to conduct head-to-head clinical studies of injection monoclonal antibody jqknews

Post date May 8, 2022 — 15:50 Post Lock

Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical and head-to-head clinical study with Pfizer's Paxlovid_ Oriental Fortune

Post date May 8, 2022 — 15:37 Post Lock

Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer's Paxlovid conducts head-to-head clinical research

Post date May 8, 2022 — 13:24 Post Lock

Nuggets for innovative drugs Junshi Bio’s new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research

Post date May 8, 2022 — 13:23 Post Lock

Want to see more data? Registered subscribers can see all the data.